Clinical Trials

Pacira Biosciences

IRB
Details
Info
EMC-IRB-25-045
A Phase 3, Multicenter, Randomized, Double-Blind, Single-Dose Study to Evaluate the Efficacy and Safety of ZILRETTA in Participants with Glenohumeral Osteoarthritis
 
Cookie Disclaimer: By using or otherwise accessing the website, you agree to that this website uses cookies and similar technologies, including those provided by vendors, for various purposes, such as to support website performance, features, and analytics (for example, Google Analytics). These cookies may process data such as IP addresses, including for them to function properly. Cookie vary across the website, including per webpage. For more information, see the Website Privacy Policy. Use or other access to this website is subject to the Website Terms and Conditions.